AAlphabet is down twelve percent today after earnings, and the market is not happy about how much cash is walking out the door.
BThe free cash flow number was ugly. They burned more than analysts expected and kept the spending guidance unchanged. That's a signal.
ABut the revenue was solid, search and cloud are fine. The market's punishing them for building AI capacity. Is that fair?
BIt's not about fair, it's about cash. When you say you're spending tens of billions on data centers and you don't give a clear path to return, investors get nervous.
ABut Google has one of the strongest balance sheets in the world. They can afford it. And if they don't spend, they fall behind in AI.
BThat's the thing—everyone's spending like crazy. Microsoft, Meta, Amazon. The question is whether the returns will ever justify it. A twelve percent drop says the market isn't sure.
AThe market is often wrong in the short term. The same market that panicked about cloud spending a decade ago. Look where that got us.
BCloud was different. It was a clear revenue story. AI is more speculative. They're building for a demand that might not show up at the prices they hope.
AI think the risk is overblown. Google has been here before. But I admit the cash flow number was worse than expected.
BAnd that's my point. They can't keep burning cash forever. At some point, the bill comes due.
BSpeaking of spending money, Eli Lilly just told us the obesity drug market is nowhere near done. Sales of Zepbound and Mounjaro surged again.
AThe stock's been a monster, and the CEO says there's room for dramatic expansion. That's a bold statement when the market's already huge.
BBut he's right. Most people who could benefit aren't on the drugs yet, because of access, cost, stigma. The runway is long.
ACost is the big issue. These drugs are expensive, and insurers push back. Unless prices come down, that expansion could be slow.
BTell that to the people paying out of pocket. The demand is there. If insurance covers more, this becomes a blockbuster decade.
AI'm not saying it won't grow; I'm saying the pace depends on pricing. Lilly's raised its outlook, but the stock's already priced for a lot.
BFair, but the numbers today were strong. That's not a story to dismiss.
AHere's one that'll start a fight: a post on X lists six big banks that 'pay you to hold them'—Bank of America, JPMorgan, Citi, Wells Fargo, Goldman, Morgan Stanley.
BPay you to hold them? That's one way to describe a dividend.
AThe dividends are real, but let's be clear: if you're a customer, not a shareholder, those banks pay you almost nothing. Savings rates at the big banks are still near zero.
BSo the post is technically true but completely misleading. Classic engagement bait.
AExactly. Those dividends are for shareholders, not for people with savings accounts.
BOne more quick one: Norwegian Cruise Line shares jumped thirteen percent after earnings beat and guidance raised. Bookings improved, but they're still below the company's optimal range.
ACruise demand has been strong, but the word 'optimal' is doing a lot of heavy lifting there. They're not filling ships like they want.
BStill, a beat is a beat. And the stock's reacting like it's smooth sailing. Good for the industry.
AI'd be more cautious. Fuel costs, labor, the consumer. A lot can go wrong.
BAll true, but today the market's rewarding them. We'll see.